Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
NCT02183792Phase 4Completed
- Sponsor
- University of Southern California
- Start
- Dec 2014
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in heart failure (HF), hyponatremia, sponsored by University of Southern California. Started Dec 2014; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)hyponatremia
Beyond the preview
Go deeper on NCT02183792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183792.